BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2020 12:21:39 PM | Browse: 552 | Download: 1081
 |
Received |
|
2020-03-14 02:59 |
|
Peer-Review Started |
|
2020-03-14 03:05 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-22 19:10 |
|
Revised |
|
2020-04-26 00:44 |
|
Second Decision |
|
2020-07-01 10:45 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-07-04 03:55 |
|
Articles in Press |
|
2020-07-04 03:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-12 22:02 |
|
Typeset the Manuscript |
|
2020-07-22 02:03 |
|
Publish the Manuscript Online |
|
2020-07-24 12:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xing-Tong Wang, Wei Guo, Mo Sun, Wei Han, Zhong-Hua Du, Xiu-Xiu Wang, Bei-Bei Du and Ou Bai |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Grant from Department of Finance of Jilin Province |
2018SCZWSZX-031 |
|
| Corresponding Author |
Ou Bai, MD, PhD, Chief Doctor, Professor, Department of Hematology, The First Hospital of Jilin University, Jilin Provincial Hematology Research Institute, National key Discipline, No. 71, Xinmin Street, Changchun 130021, Jilin Province, China. baiou@jlu.edu.cn |
| Key Words |
Hepatosplenic T-cell lymphoma; Gamma-delta T-cell lymphoma; Chidamide; Novel agent; Case report; |
| Core Tip |
Hepatosplenic T-cell lymphoma is a rare disease that progresses quickly and has poor prognosis. Patients usually show short-term rapid disease progress with a traditional inductive regimen, leaving no opportunity for hematopoietic stem cell transplantation. We employed the histone deacetylase inhibitors Chidamide combined with a dose-adjusted ifosfamide, carboplatin, etoposide regimen and Chidamide single-drug oral maintenance therapy for the management of this patient and turn out a satisfactory outcome. |
| Publish Date |
2020-07-24 12:21 |
| Citation |
Wang XT, Guo W, Sun M, Han W, Du ZH, Wang XX, Du BB, Bai O. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report. World J Clin Cases 2020; 8(14): 3122-3129 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i14/3122.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i14.3122 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
